(Q52207131)

27 April 2018

title

Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy. (English)

1 reference

27 April 2018

author name string

Viens P

1

1 reference

27 April 2018

Jacquemier J

2

1 reference

27 April 2018

Bardou VJ

3

1 reference

27 April 2018

Bertucci F

4

1 reference

27 April 2018

Penault-Llorca F

5

1 reference

27 April 2018

Puig B

6

1 reference

27 April 2018

Gravis G

7

1 reference

27 April 2018

Oziel-Taïeb S

8

1 reference

27 April 2018

Resbeut M

9

1 reference

27 April 2018

Houvenaeghel G

10

1 reference

27 April 2018

Camerlo J

11

1 reference

27 April 2018

Birbaum D

12

1 reference

27 April 2018

Hassoun J

13

1 reference

27 April 2018

Maraninchi D

14

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 April 1999

1 reference

27 April 2018

Breast Cancer Research and Treatment

published in

1 reference

27 April 2018

volume

54

1 reference

27 April 2018

page(s)

205-212

1 reference

27 April 2018

issue

3

1 reference

27 April 2018

https://scigraph.springernature.com/pub.10.1023/a:1006112927565

exact match

0 references

cites work

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

c-erbB-2 oncogene as a prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

The influence of angiogenesis research on management of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Designing therapies that target tumor blood vessels

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006112927565

7 January 2021

Identifiers

DOI

10.1023/A:1006112927565

1 reference

27 April 2018

Dimensions Publication ID

0 references

1 reference

27 April 2018